Magnetar Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,955	Closed	-$702K	–	952
2025 Q3	$702K	Sell	12,955 -14,290	-52%	-$817K	﹤0.01%	523
2025 Q2	$1.5M	Buy	+27,245	New	+$1.6M	0.01%	376
2024 Q4	–	Sell	-3,404	Closed	-$239K	–	624
2024 Q3	$239K	Sell	3,404 -5,412	-61%	-$452K	0.01%	441
2024 Q2	$726K	Buy	+8,816	New	+$734K	0.02%	302
2022 Q2	–	Sell	-3,169	Closed	-$244K	–	1678
2022 Q1	$244K	Buy	+3,169	New	+$265K	﹤0.01%	1026
2021 Q2	–	Sell	-6,287	Closed	-$475K	–	1217
2021 Q1	$475K	Buy	6,287 +1,776	+39%	+$145K	﹤0.01%	834
2020 Q4	$396K	Buy	+4,511	New	+$358K	0.01%	592
2019 Q2	–	Sell	-4,242	Closed	-$377K	–	453
2019 Q1	$377K	Buy	+4,242	New	+$393K	0.01%	291
2017 Q2	–	Sell	-16,485	Closed	-$1.45M	–	800
2017 Q1	$1.45M	Buy	+16,485	New	+$1.47M	0.02%	239
2016 Q4	–	Sell	-7,272	Closed	-$673K	–	61
2016 Q3	$673K	Buy	+7,272	New	+$685K	0.01%	317
2015 Q1	–	Sell	-89,689	Closed	-$10.6M	–	214
2014 Q4	$10.6M	Buy	89,689 +33,110	+59%	+$2.75M	0.25%	86
2014 Q3	$4.08M	Buy	56,579 +4,800	+9%	+$315K	0.09%	109
2014 Q2	$3.22M	Buy	+51,779	New	+$3.13M	0.08%	124